As anticipated, the presence of the ETV4 P433L mutation in cancer cells led to a higher incidence of tumor formation compared to the wild type cell lines, the inhibitor XAV-939 could also significantly inhibit this effect (Fig. 6C–F). This evidence concerns the gene ETV4 and cancer.